How the Complicated Urinary Tract Infection Treatment Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of theComplicated Urinary Tract Infection Treatment Market from 2025 to 2034?
The rising incidence of chronic kidney diseases (CKD) is expected to propel the growth of the complicated urinary tract infection (UTI) treatment market. CKD is increasingly common due to risk factors such as diabetes, hypertension, and an aging population. Chronic kidney disease patients are more susceptible to complicated UTIs, which can worsen kidney function. For example, the Australian Institute of Health and Welfare reported that CKD was responsible for approximately 21,800 deaths in Australia in 2022, while Kidney Care UK estimated 40,000 premature deaths annually due to CKD in the UK. These statistics highlight the urgent need for effective UTI treatments to manage complications in CKD patients.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21156&type=smp
#What Long-Term Growth Rate is Expected for theComplicated Urinary Tract Infection Treatment Market Between 2025 and 2034?
The complicated urinary tract infection treatment market has seen strong growth in recent years. It is expected to increase from $8.87 billion in 2024 to $9.47 billion in 2025 at a CAGR of 6.8%. The historical growth factors include a rising prevalence of urinary tract infections, increasing antibiotic resistance, a growing geriatric population, higher hospitalization rates, and greater awareness of UTIs.
The complicated urinary tract infection treatment market is expected to grow substantially, reaching $12.13 billion in 2029 at a CAGR of 6.4%. Growth will be driven by the increasing prevalence of multidrug-resistant infections, a stronger emphasis on precision medicine, rising healthcare expenditure, the growing adoption of rapid diagnostic testing, and government funding for research initiatives. Major trends include improvements in diagnostic technologies, expanded healthcare access in emerging regions, development of novel antibiotics, innovations in diagnostic tools, and the increasing use of combination therapies for enhanced treatment effectiveness.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21156
How Are Market Trends and Innovations Revolutionizing theComplicated Urinary Tract Infection Treatment Industry in Recent Times?
Major companies operating in the complicated urinary tract infection (cUTI) treatment market are focusing on addressing antibiotic resistance by developing novel antibiotics to improve treatment efficacy and combat multidrug-resistant pathogens. For example, in February 2024, Allecra Therapeutics, a Germany-based biopharmaceutical company, announced FDA approval of EXBLIFEP (cefepime/enmetazobactam) for treating cUTIs in adults. The treatment showed a superior composite response (clinical cure and microbiological eradication) in 79.1% of patients, compared to 58.9% of patients treated with the standard therapy (piperacillin/tazobactam). Additionally, Allecra secured a five-year marketing exclusivity extension under the GAIN Act, which incentivizes the development of new anti-infective therapies.
Which Key Market Players Are Shaping the Future and Growth of theComplicated Urinary Tract Infection Treatment Market?
Major companies operating in the complicated urinary tract infection treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., AstraZeneca PLC, Fresenius Kabi AG, GlaxoSmithKline plc, bioMérieux SA, Shionogi & Co. Ltd., Cipla Limited, Santen Pharmaceutical Co. Ltd., Orchid Pharma Limited, Melinta Therapeutics Inc., Spero Therapeutics Inc., Nabriva Therapeutics AG, Venatorx Pharmaceuticals Inc., Recce Pharmaceuticals Ltd, MerLion Pharmaceuticals Pte. Ltd., Entasis Therapeutics Holdings Inc., Allecra Therapeutics GmbH, Allergan Inc.
Order Your Report Now For A Swift Delivery:
What Are the Core Segments of the Complicated Urinary Tract Infection Treatment Market, and How Do They Contribute to Growth?
The complicated urinary tract infection treatment market covered in this report is segmented –
1) By Drug Class: Penicillin And combinations, Quinolones, Cephalosporin, Azoles And Amphotericin B, Nitro furans
2) By Distribution Channel: Hospital Pharmacies, Gynecology And Urology Clinics, Drug stores
3) By Application: Urethritis, Cystitis, Pyelonephritis
Subsegments:
1) By Penicillin And Combinations: Aminopenicillins, Beta-Lactamase Inhibitor Combinations
2) By Quinolones: Fluoroquinolones, Non-Fluoroquinolones
3) By Cephalosporin: First-Generation Cephalosporins, Second-Generation Cephalosporins, Third-Generation Cephalosporins, Fourth-Generation Cephalosporins, Fifth-Generation Cephalosporins
4) By Azoles And Amphotericin B: Triazoles, Imidazoles, Polyene Antifungals
5) By Nitrofurans: Nitrofurantoin, Furazolidone
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=21156&type=smp
What Regions Are Dominating the Complicated Urinary Tract Infection Treatment Market Growth?
North America was the largest region in the complicated urinary tract infection treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complicated urinary tract infection treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Complicated Urinary Tract Infection Treatment Market 2025, By The Business Research Company:
Immuno-Oncology Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report
Immunosuppressants Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/immunosuppressant-global-market-report
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
